1 min read
Add as a preferred source on GoogleJasper Therapeutics Sets 1-for-30 Reverse Split for Nov. 6
The share consolidation is expected to reduce its outstanding common shares from nearly 33.3 million to about 1.11 million.
Jasper Therapeutics, Inc. (JSPR) plans to consolidate its common shares in a 1-for-30 reverse split that takes effect Friday, Nov. 6.
The transaction is expected to leave about 1.11 million common shares outstanding, compared with nearly 33.3 million before the change. Under the split ratio, each group of 30 existing shares becomes one share.
JSPR shares fell more than 14% Wednesday after the announcement.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.